SCHEMBL8425316

SCHEMBL8425316

COC(CCCCC1c2cccc(O)c2C(=O)c2c(O)cccc21)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.39
SLC37A4 O43826 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8425196 0.96 CES2 (0.38) CES2
SCHEMBL8427333 0.85 CES2 (0.36) CES2
SCHEMBL8427351 0.82 P4HB (0.39)
SCHEMBL10490983 0.76 CES2 (0.63) CES2
SCHEMBL8569420 0.72 EPHX1 (0.38)
SCHEMBL9185267 0.72 L3MBTL1 (0.53)
SCHEMBL9182611 0.70 L3MBTL1 (0.50)
SCHEMBL10630402 0.69 CES2 (0.52) CES2
SCHEMBL8624814 0.69 ELANE (0.52) CES2SLC37A4
SCHEMBL8077268 0.68 CES2 (0.45) CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5952390-A ANTIINFLAMMATORY AGENTS; TREATMENT FOR PSORIASIS TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 1999-09-14 US disclosed